Icatibant Acetate

Overview

Icatibant acetate is a selective antagonist of bradykinin B2 receptors. Icatibant is a medication approved for the treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency. Sequence: DArg-Arg-pro-Hyp-Gly-Thi-Ser-DTic-Oic-Arg Source summary: Icatibant acetate peptide for bradykinin receptor studies. High-quality synthesis, fast delivery, and customizable options for research and clinical trials.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cardiovascular and blood system | Bradykinin Receptor

Product Information

• Catalog No.: B0084-185841
• CAS No.: 138614-30-9
• Molecular Formula: C59H89N19O13S.xC2H4O2
• Molecular Weight: 1304.52 (free base)
• Purity: ≥95%
• Storage: Store at -20°C
• Solubility: Soluble in Water

Source

Original product source